Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
SH3TC2, PMP2, and BSCL2 genes are related to autosomal recessive (AR) Charcot-Marie-Tooth (CMT) disease type 1, autosomal dominant (AD)-CMT1, and AD-CMT2, respectively.
|
29336362 |
2018 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the ganglioside-induced differentiation-associated protein 1 gene (GDAP1) cause Charcot-Marie-Tooth type 2 (CMT2), a severe autosomal recessive form of neuropathy associated with axonal phenotypes.
|
19381883 |
2009 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We analyzed the HSPB1 and HSPB8 genes in a large clinically well-characterized series of dHMN and CMT type 2 (CMT2) cases and families using linkage analysis and direct sequencing of these genes.
|
18832141 |
2008 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Less frequently, axonal CMT (CMT2) associated with MPZ mutations has been described.
|
17940173 |
2007 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Two major types can be distinguished based on electrophysiologic phenotypes: CMT type 1 (CMT1) displays uniformly decreased nerve conduction velocity associated with a demyelinating hypertrophic neuropathy, and CMT type 2 (CMT2) displays normal or near-normal nerve conduction velocity associated with a neuronal defect.
|
8128981 |
1993 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Charcot-Marie-Tooth disease (CMT) is a heterogeneous disorder and is traditionally classified into two major types, CMT type 1 (CMT1) and CMT type 2 (CMT2).
|
12402337 |
2002 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Twelve CMT patients who did not have decreased nerve conduction velocities consistent with a diagnosis of CMT type 2 (CMT2) were found not to have the CMT1A duplication.
|
8105684 |
1993 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The neuronal form of this disorder is referred to as Charcot-Marie-Tooth type II disease (CMT2).
|
7573046 |
1995 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Recently a set of mutations in the neurofilament light gene (NF-L) was reported in patients suffering from axonal and demyelinating forms of Charcot-Marie-Tooth disease (CMT1 and CMT2).
|
15535039 |
2004 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The present study therefore provides evidence for genetic heterogeneity between the hypertrophic and the neuronal forms of Charcot-Marie-Tooth disease and demonstrates that the CMT2 gene is not allelic to either of the CMT1 genes mapped to date.
|
1733853 |
1992 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Point mutations in the coding region of the myelin genes, peripheral myelin protein 22 (PMP22), myelin protein zero (MPZ) or connexin 32 (Cx32) have been reported in CMT patients, including CMT type 1 (CMT1), CMT type 2 (CMT2) and Déjérine-Sottas neuropathy (DS) patients, and only in the coding region of PMP22 in HNPP families lacking a deletion.
|
9187667 |
1997 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Three loci are known for the autosomal dominant forms of axonal CMT (CMT2), but none have yet been identified for autosomal recessive axonal CMT (ARCMT2).
|
10441578 |
1999 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The other CMT families with dominant inheritance but without duplication included one family with CMT1B (demyelinating CMT mapped on chromosome 1) (1.6%), 14 families with CMT2 axonal neuropathy (22.2%), and 10 families with X-linked dominant CMT (15.9%).
|
8413376 |
1993 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in dynamin 2 (DNM2) have been associated with autosomal dominant centronuclear myopathy, dominant intermediate Charcot-Marie-Tooth (CMT) type B and CMT2.
|
18394888 |
2008 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Electroneuromyography revealed an axonal motor and sensory neuropathy in 3 different families, very evocative of type II Charcot-Marie-Tooth (CMT2) disease, although none had mutations in the known CMT2 genes.
|
24804794 |
2014 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Charcot-Marie-Tooth (CMT) disease is genetically heterogeneous and subdivided into demyelinating (CMT 1) and axonal (CMT 2) types based on neurophysiology findings.
|
19809938 |
2009 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the mitochondrial fusion protein mitofusin 2 (MFN2) are the most commonly identified cause of Charcot-Marie-Tooth type 2 (CMT2), a dominantly inherited disease characterized by degeneration of peripheral sensory and motor axons.
|
17215403 |
2007 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Charcot-Marie-Tooth disease (CMT) is a group of clinically and genetically heterogeneous neuropathies classically divided into demyelinating (CMT1) and axonal forms (CMT2).
|
20537790 |
2010 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Hereditary motor and sensory neuropathy (HMSN), also known as Charcot-Marie-Tooth disease (CMT) is a group of clinically and genetically heterogeneous neuropathies classically divided into demyelinating (CMT1) and axonal forms (CMT2).
|
19344920 |
2009 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Human CMT2-FiPS4F1 cell line was generated from fibroblasts of a patient with Charcot-Marie-Tooth disease harbouring the following mutations in the GDAP1 gene in heterozygosis: p.Q163X/p.T288NfsX3.
|
28395795 |
2017 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Clinical, electrophysiological and genetic linkage studies were performed on a large autosomal dominant family with Charcot-Marie-Tooth axonal neuropathy type 2 (CMT2) with 38 members of which 14 were affected.
|
8872480 |
1996 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
CMT1 (motor conduction velocity (MCV) <38 m/s), CMT2 (MCV >38 m/s) and CMT intermediate (MCV 25-45 m/s) were found in 48.2%, 49.4% and 2.4% of the families.
|
20482598 |
2011 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In previous studies, MFN2 mutations have been linked to neurological disorders including CMT type 2 (CMT2).
|
26956144 |
2016 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the myelin protein zero (MPZ) gene have been associated with different Charcot-Marie-Tooth disease (CMT) phenotypes, including classical demyelinating CMT1B and the axonal form of the disease (CMT2).
|
19293842 |
2009 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Nerve conduction velocities and pathological studies were compatible with axonal CMT (CMT2).
|
18812441 |
2008 |